UTHR-a Promising Biotech in the works here? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : UTHR-a Promising Biotech in the works here?

UTHR 438.62

-1.5%

9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: debra vogt who wrote (13)	8/28/1999 2:49:00 PM
From: kendall harmon	of 66

UTHR could still go higher next week, depending on the outcome of the paper to be delivered in Barcelona this coming Tuesday morning European time. The company is going to have an accompanying press release Tuesday evening U.S. time (confirmed to me through communications with IR). The market for their lead drug, UT-15, is very large, consider just one fact: The prevalence of x-ray measured pulmonary arteries with abnormally large diameters -- an indication of pulmonary hypertension -- is 13% of men over age 34. This means there may be tens of millions of people worldwide with pulmonary hypertension. The prevalence of people with diagnosed Primary Pulmonary Hypertension (PPH) is about ten persons per million. The number of diagnosed case of secondary pulmonary hypertension is approximately 50,000 persons in the U.S.and Europe.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next